Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Works matching IS 11707690 AND DT 2012 AND VI 30 AND IP 3
Results: 10
1
2
Common Drug Review recommendations: an evidence base for expectations?
- Published in:
- 2012
- By:
- Publication type:
- journal article
3
Measuring quality of life in patients with schizophrenia: an update.
- Published in:
- 2012
- By:
- Publication type:
- journal article
4
Rufinamide A Pharmacoeconomic Profile of its Use as Adjunctive Therapy in Lennox-Gastaut Syndrome.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 3, p. 247, doi. 10.2165/11208630-000000000-00000
- By:
- Publication type:
- Article
5
Common Drug Review Recommendations An Evidence Base for Expectations.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 3, p. 229, doi. 10.2165/11593030-000000000-00000
- By:
- Publication type:
- Article
6
Methodological Quality of Economic Evaluations of New Pharmaceuticals in the Netherlands.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 3, p. 219, doi. 10.2165/11539850-000000000-00000
- By:
- Publication type:
- Article
7
Pricing Human Papillomavirus Vaccines Lessons from Italy.
- Published in:
- 2012
- By:
- Publication type:
- Opinion
8
Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001-7.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 3, p. 197, doi. 10.2165/11587150-000000000-00000
- By:
- Publication type:
- Article
9
Measuring Quality of Life in Patients with Schizophrenia An Update.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 3, p. 183, doi. 10.2165/11594470-000000000-00000
- By:
- Publication type:
- Article
10
Population- versus Cohort-Based Modelling Approaches.
- Published in:
- PharmacoEconomics, 2012, v. 30, n. 3, p. 171, doi. 10.2165/11593050-000000000-00000
- By:
- Publication type:
- Article